Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: Report of three cases

Journal of Dermatology

Volumn 34, Issue 5, 2007, Pages 328-332

  Hasegawa, Toshio ^a   Mizoguchi, Masayuki ^a   Haruna, Kunitaka ^a   Mizuno, Yuki ^a   Muramatsu, Shigenori ^a   Suga, Yasushi ^a   Ogawa, Hideoki ^a   Ikeda, Shigaku ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Amnion; Epidermolysis bullosa; Skin ulcer

Indexed keywords

ADULT; AMNION; ARTICLE; CASE REPORT; CLINICAL EFFECTIVENESS; DEBRIDEMENT; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPITHELIUM; FEMALE; GRANULATION TISSUE; HUMAN; MALE; RECESSIVE INHERITANCE; SKIN ULCER; TISSUE REGENERATION; TREATMENT DURATION; TREATMENT RESPONSE; WOUND;

ADULT; AMNION; BIOLOGICAL DRESSINGS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; HUMANS; MALE; SKIN ULCER;

EID: 34047203708     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00281.x     Document Type: Article

References (27)

1. Fine JD, Bauer EA, Briggaman RA et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 1991; 24: 119-135.
2. Regauer S, Seiler GR, Barrandon Y, Easley KW, Compton CC. Epithelial origin of cutaneous anchoring fibrils. J Cell Biol 1990; 111: 2109-2115.
3. Ryynanen J, Sollberg S, Parente MG, Chung LC, Christiano AM, Uitto J. Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes. J Clin Invest 1992; 89: 163-168.
4. Trelford JD, Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 1979; 134: 833-845.
5. Bose B. Burn wound dressing with human amniotic membrane. Ann R Coll Surg Engl 1979; 61: 444-447.
6. Bennett JP, Matthews R, Faulk WP. Treatment of chronic ulceration of the legs with human amnion. Lancet 1980; 1: 1153-1156.
7. Wollina U, Konrad H, Fisher T et al. Recessive epidermolysis bullosa dystrophicans (Hallopeau-Siemens) - improvement of wound healing by autologous epidermal grafts on an esterified hyaluronic acid membrane. J Dermatol 2001; 28: 217-220.
8. Carter DM, Lin AN, Varghese MC, Caldwell D, Pratt LA, Eisinger M. Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol 1987; 17: 246-250.
9. McGrath JA, Schofield OM, Ishida-Yamamoto A et al. Cultured keratinocyte allografts and wound healing in severe dystrophic epidermolysis bullosa. J Am Acad Dermatol 1993; 29: 407-419.
10. McGuire J, Birchall N, Cuono C et al. Successful engraftment of allogeneic keratinocyte cultures in recessive dystrophic epidermolysis bullosa (abstract). Clin Res 1987; 35: 702A.
11. Eisenberg M, Llewellyn DM, Moran K, Kerr A. Successful engraftment of cultured human epidermal allograft in a child with recessive dystrophic epidermolysis bullosa. Med J Aust 1987; 147: 520-521.
12. Schofield OMV, Cassella JP, Navsaria HA et al. Cultured keratinocyte allografts in dystrophic epidermolysis bullosa: preliminary observations (abstract). Br J Dermatol 1990; 123 (Suppl 37): 66A.
13. Verplancke P, Beele H, Monstrey S, Naeyaert JM. Treatment of dystrophic epidermolysis bullosa with autologous meshed split-thickness skin grafts and allogeneic cultured keratinocytes. Dermatology 1997; 194: 380-382.
14. Hasegawa T, Suga Y, Mizoguchi M et al. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004; 50: 803-804.
15. Martinez Pardo ME, Reyes Frias ML, Ramos Duron LE et al. Clinical application of amniotic membranes on a patient with epidermolysis bullosa. Ann Transplant 1999; 4: 68-73.
16. Chuck RS, Graff JM, Bryant MR, Sweet PM. Biomechanical characterization of human amniotic membrane preparations for ocular surface reconstruction. Ophthalmic Res 2004; 36: 341-348.
17. Maral T, Borman H, Arslan H, Demirhan B, Akinbingol G, Haberal M. Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing. Burns 1999; 25: 625-635.
18. Rejzek A, Weyer F, Eichberger R, Gebhart W. Physical changes of amniotic membranes through glycerolization for the use as an epidermal substitute. Light and electron microscopic studies. Cell Tissue Bank 2001; 2: 95-102.
19. Burgos H. Angiogenic and growth factors in human amnio-chorion and placenta. Eur J Clin Invest 1983; 13: 289-296.
20. Faulk WP, Matthews RN, Stevens PJ, Bennet JP, Burgos H, Hsi B. Human amnion as an adjunct in wound healing. Lancet 1980; 1: 1156-1158.
21. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 2000; 20: 173-177.
22. Rao TV, Chandrasekharam V. Use of dry human and bovine amnion as a biological dressing. Arch Surg 1981; 116: 891-896.
23. Culp LA, Murray BA, Rollins BJ. Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct 1979; 11: 401-427.
24. Lin SD, Lai CS, Hou MF, Yang CC. Amnion overlay meshed skin autograft. Burns Incl Therm Inj 1985; 11: 374-378.
25. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978; 75: 871-875.
26. Splichalova A, Trebichavsky I, Muneta Y, Mori Y, Splichal I. Effect of bacterial virulence on IL-18 expression in the amnion infected with Escherichia coli. Am J Reprod Immunol 2005; 53: 255-260.
27. Splichal I, Trebichavsky I. Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections. Folia Microbiol (Praha) 2001; 46: 345-351.